Hot Pursuit     28-Oct-21
Alembic Pharmaceuticals Ltd continues to fall
Alembic Pharmaceuticals Ltd is quoting at Rs 750.8, down 0.79% on the day as on 13:24 IST on the NSE. The stock tumbled 22.61% in last one year as compared to a 54.42% rally in NIFTY and a 23.73% spurt in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 750.8, down 0.79% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is down around 1.03% on the day, quoting at 18022.6. The Sensex is at 60545.67, down 0.98%.Alembic Pharmaceuticals Ltd has eased around 5.53% in last one month.Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 3.57% in last one month and is currently quoting at 14094.25, down 1.45% on the day. The volume in the stock stood at 69473 shares today, compared to the daily average of 4.61 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 751.55, down 0.78% on the day. Alembic Pharmaceuticals Ltd tumbled 22.61% in last one year as compared to a 54.42% rally in NIFTY and a 23.73% spurt in the Nifty Pharma index.

The PE of the stock is 14.18 based on TTM earnings ending June 21.

Previous News
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
  Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
 ( Hot Pursuit - 19-Jan-23   14:12 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
  Alembic Pharma announces US FDA nod for topical corticosteroid
 ( Hot Pursuit - 25-Apr-22   11:32 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Brexpiprazole Tablets
 ( Corporate News - 09-Mar-23   10:39 )
  Alembic Pharma Q4 PAT zooms to Rs 153 cr; R&D spend at Rs 136 crore
 ( Hot Pursuit - 06-May-23   14:44 )
  Board of Alembic Pharmaceuticals recommends Final Dividend
 ( Corporate News - 05-May-23   17:26 )
  Alembic Pharmaceuticals Ltd soars 1.11%
 ( Hot Pursuit - 05-Apr-22   13:05 )
Other Stories
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
  Real Estate stocks slide
  05-Jul-24   14:00
Back Top